Montinex
Montinex (Montelukast) is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1). The cysteinyl leukotrienes (LTC4, LTD4, LTE4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils.
Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.
Features
| Product Name | Montinex |
| Generic Name | Montelukast Sodium |
| Formulation | ODTs, Tablets & Chewable Tablet |
| Available Pack Size | 30’s, 30’s, 30’s, 50’s & 30’s |
| Available Strength | 4 mg ODT, 5 mg ODT, 10 mg, 10 mg R Tablet & 10 mg Chewable Tablet |